Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2021 Earnings Conference Call May 13, 2021 2:00 PM ET Company Participants Clint Tomlinson - Investor Relations Christopher Missling - President and Chief Executive Officer Sandra Boenisch - Principal Financial Officer & Treasurer Conference Call Participants Charles Duncan - Cantor Fitzgerald Jeffrey Cohen - Ladenburg Thalmann Raghuram Selvaraju - H.C. Wainwright Tom Bishop - BI Research Clint Tomlinson Thank you and good afternoon, everyone. We appreciate you jo ...

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2021 Earnings Conference Call February 11, 2021 4:30 PM ET Company Participants Clint Tomlinson - Investor Relations Christopher Missling - President and Chief Executive Officer Sandra Boenisch - Principal Financial Officer Conference Call Participants Charles Duncan - Cantor Ram Selvaraju - H.C. Wainwright Robert LeBoyer - Ladenburg Thalmann Tom Bishop - BI Research Operator Good afternoon. My name is Aaron, and I will be your conference call operator today. Welc ...

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q4 2020 Earnings Conference Call December 28, 2020 4:30 PM ET Company Participants Clint Tomlinson - Investor Relations Dr. Christopher Missling - President and Chief Executive Officer Sandra Boenisch - Principal Financial Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald Robert LeBoyer - Ladenburg Thalmann Tom Bishop - BI Research Operator Good afternoon. My name is Vanessa and I'll be your conference call operator today. Welcome to the Anavex ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to________________ Commission file number: 001-37606 ANAVEX LIFE SCIENCES CORP. (Exact name of registrant as specified in its charter) Nevada 98-06084 ...

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q3 2020 Results Conference Call August 6, 2020 11:00 AM ET Company Participants Clint Tomlinson - IR Dr. Christopher Missling - President and CEO Sandra Boenisch - Principal Financial Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald Edward Marks - H.C. Wainwright Operator Welcome to the Anavex Life Sciences to announce fiscal 2020 Third Quarter Financial Results Conference Call. My name is Rebecca, and I will be your operator for today's call. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____to _____ Commission File Number: 001-37606 ANAVEX LIFE SCIENCES CORP. (Exact name of registrant as specified in its charter) Nevada 98-0608404 (State or oth ...

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Clint Tomlinson – Investor Relations Christopher Missling – President and Chief Executive Officer Sandra Boenisch – Principal Financial Officer Conference Call Participants Raghuram Selvaraju – H.C. Wainwright Tom Bishop – BI Research Operator Good afternoon. My name is Adriane, and I will be your conference call operator today. Welcome to the Anavex Life Sciences Fiscal 2020 Second Quarter ...